Prelude Therapeutics Incorporated Common Stock — Institutional Ownership

Which tracked institutions hold PRLD, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

16
Funds holding
$19222064
Total value held
Buying
13 added/new · 2 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $9580681 1797501 +1475615 +458.43%
2 Morgan Stanley $2685574 503860 +181699 +56.40%
3 State Street Corp $2285435 428787 +290556 +210.20%
4 Ubs Group Ag $1699188 318797 +318797 NEW BUY
5 Northern Trust Corp $1282393 240599 +190479 +380.05%
6 Goldman Sachs Group Inc $644045 120834 -115635 -48.90%
7 Bank Of New York Mellon Corp $363436 68187 +68187 NEW BUY
8 Invesco Ltd. $185175 34742 +34742 NEW BUY
9 Wells Fargo & Company/Mn $134982 25325 +25325 NEW BUY
10 Bank Of America Corp /De/ $127254 23875 -32650 -57.76%
11 Barclays Plc $77439 14529 +5929 +68.94%
12 Citigroup Inc $69466 13033 +13032 +1303200.00%
13 Jpmorgan Chase & Co $66742 13538 +13476 +21735.48%
14 Royal Bank Of Canada $14000 2658 +327 +14.03%
15 Pnc Financial Services Group, Inc. $6242 1171 Held
16 Amalgamated Financial Corp. $12 1764 +1764 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.